nimbecidine
from neem, Azadirachta indica; 0.3% azadirachtin, neem oil 90.5%, hydroxyel 5%, epichlorohydrate 0.5%, aromax 3%
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Body Weight (Weight, Body)
|
2. | Congenital Abnormalities (Deformity)
12/01/2022
- " After treatment with Nimbecidine Plus and MOC, several cytomorphological deformities (cytoplasmic and nuclear membrane disintegration, chromatin condensation, pyknosis, karyorrhexis, karyolysis, nuclear vacuolation, altered cell shape, cellular coagulation, cytoplasmic discharge, vacuolation) were observed in hyalinocytes, small granule haemocytes and large granule haemocytes with modulation of their relative percentages at different exposure times. "
|
|
Related Drugs and Biologics
Related Therapies and Procedures